Adaptive Biotechnologies: Q4 Earnings Snapshot

SEATTLE (AP) — SEATTLE (AP) — Adaptive Biotechnologies Corp. (ADPT) on Tuesday reported a loss of $40.1 million in its fourth quarter.

The Seattle-based company said it had a loss of 28 cents per share.

The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 37 cents per share.

The life-sciences research company posted revenue of $55.2 million in the period, which fell short of Street forecasts. Five analysts surveyed by Zacks expected $55.9 million.

For the year, the company reported that its loss narrowed to $200.2 million, or $1.40 per share. Revenue was reported as $185.3 million.

Adaptive Biotechnologies expects full-year revenue in the range of $205 million to $215 million.

Adaptive Biotechnologies shares have risen 14% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $8.68, a decline of 41% in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on ADPT at

Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up